Pascale Lehoux

Department of Health Management, Evaluation and Policy, School of Public Health, University of Montreal, Montréal, QC, Canada | Institute of Public Health Research of University of Montreal (IRSPUM), Montréal, QC, Canada

[ 2 ] - Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies

Background New technologies constitute an important cost-driver in healthcare, but the dynamics that lead to their emergence remains poorly understood from a health policy standpoint. The goal of this paper is to clarify how entrepreneurs, investors, and regulatory agencies influence the value of emerging health technologies.   Methods Our 5-year qualitative research program examined the proces...

[ 3 ] - What Health System Challenges Should Responsible Innovation in Health Address? Insights From an International Scoping Review

Background While responsible innovation in health (RIH) suggests that health innovations could be purposefully designed to better support health systems, little is known about the system-level challenges that it should address. The goal of this paper is thus to document what is known about health systems’ demand for innovations.   Methods We searched 8 databases to perfo...

[ 5 ] - Transforming Disciplinary Traditions; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”

Grutters et al show that economic assessments can inform the development of new health technologies at an early stage. This is an important contribution to health services and policy research, which implies a “shift away” from the more traditional forms of academic health economic modeling. Because transforming established disciplinary traditions is both valuable and de...

نویسندگان همکار